WO1995021637A1 - Membrane with anti-viral properties - Google Patents

Membrane with anti-viral properties

Info

Publication number
WO1995021637A1
WO1995021637A1 PCT/GB1995/000194 GB9500194W WO9521637A1 WO 1995021637 A1 WO1995021637 A1 WO 1995021637A1 GB 9500194 W GB9500194 W GB 9500194W WO 9521637 A1 WO9521637 A1 WO 9521637A1
Authority
WO
WIPO (PCT)
Prior art keywords
membrane
fullerene
coating
layers
langmuir
Prior art date
Application number
PCT/GB1995/000194
Other languages
French (fr)
Inventor
Michael Charles Petty
Martin Robert Bryce
Geoffrey Williams
Original Assignee
British Technology Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Limited filed Critical British Technology Group Limited
Publication of WO1995021637A1 publication Critical patent/WO1995021637A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2604/00Fullerenes, e.g. C60 buckminsterfullerene or C70

Definitions

  • This invention relates to a membrane with anti-viral properties, to a method of imparting anti-viral properties to a membrane, and to products such as surgical gloves and condoms made of such a membrane, which itself may typically be of rubber, such as latex rubber, or polyurethane.
  • products such as surgical gloves and condoms made of such a membrane, which itself may typically be of rubber, such as latex rubber, or polyurethane.
  • An important virus whose activity it would be appropriate to curb with such products is the human immuno-deficiency virus HIV.
  • a membrane of for example polyurethane or rubber, e.g. latex rubber, according to the invention carries a coating of from one to ten, preferably 1 or 2, layers of one or more fullerenes.
  • the fullerene(s) may be applied by way of dispersion in a gel or lubrication layer, applied conventionally to the membrane, or as follows.
  • a method of coating a membrane comprises applying one or more Langmuir-Blodgett coatings of fullerene to the membrane.
  • the fullerene may be dissolved in an aromatic and/or hydrophobic compound on a hydrophilic (e.g. water) subphase.
  • the fullerene may be codissolved with a phospholipid or fatty acid, e.g. arachidic acid, in a mole proportion of 1 :(1-10) and/or may be substituted with alkyl chains C j -C j g or with functionalised chains containing amine, hydroxyl or carboxy lie acid groups, e.g. may be 1 -tertbutyl- 1.9-dihydrofullerene-60.
  • the invention extends to products such as surgical gloves and condoms made of a membrane which has a coating as set forth above.
  • a Langmuir-Blodgett trough of a constant perimeter design of floating boom was housed in a microelectronics-grade clean room.
  • the subphase in the trough was ultra-pure water (pH 5.7 ⁇ 0.1, temperature 20 ⁇ 2°C) obtained by reverse osmosis, deionization and
  • This arrangement is believed to be of vertically aligned fatty acid molecules in a close-packed ordered arrangement on the subphase (water) surface, with the fullerene molecules on tog. This arrangement is transferred "as is” to a solid substrate dipped into the Langmuir-Blodgett trough.
  • a substrate When a substrate is dipped into the trough and removed, it may have adhering to it a layer of aligned molecules which became attached: on the downstroke only (X-type deposition), on the downstroke and again on the upstroke (Y-type deposition), or on the upstroke only (Z-type deposition).
  • the thoroughness or efficiency of deposition is measured by the deposition ratio, defined as (change in enclosed surface area of trough)/(dipped area of substrate).

Abstract

A condom with anti-viral properties is made by Langmuir-Blodgett coating onto latex rubber of 1 mole part C60 fullerene and 4 mole parts arachidic acid.

Description

MEMBRANE WITH ANTI- VIRAL PROPERTIES
This invention relates to a membrane with anti-viral properties, to a method of imparting anti-viral properties to a membrane, and to products such as surgical gloves and condoms made of such a membrane, which itself may typically be of rubber, such as latex rubber, or polyurethane. An important virus whose activity it would be appropriate to curb with such products is the human immuno-deficiency virus HIV.
It had been thought from laboratory studies in the mid-1980s that the spermicide nonoxynol-9 killed this virus, but more recent studies suggest that this compound can increase the chance of HUV transmission compared with using a placebo (Guardian, 3 November 1993). Therefore the search for a different anti-viral agent is urgent.
It has been suggested by a group from Emory University, Atlanta, Georgia, USA, that the football-shaped carbon compound buckminsterfullerene Cgø should block the action of the enzyme "reverse transcriptase", with which the virus converts its RNA into the DNA essential for replication (Neue Zϋrcher Zeitung 1 December 1993). Independently, Friedman et al. from the University of California postulated and verified that Cgø was of just the right size to block the enzyme HIV-protease, which has the form of an open cylinder in the bore of which is a site where two aspartic acid groups catalyse the hydrolysis (i.e. destruction) of the peptide bonds of the protein being attacked by the enzyme. The Cgø molecule snugly fits this site, stopping the enzyme from functioning (J. American Chemical Society, 1993, pp 6510-2).
However, the possibility of exploiting these welcome properties in the context of membrane products has not been considered because it is such an improbable combination technically, in that a strong chemical bond uncharacteristic of buckminsterfullerene is normally required for a monomolecular layer to adhere to a substrate.
Independently of this, Williams et al of the University of Durham have succeeded in forming Langmuir-Blodgett films of fullerenes on to various rigid bulk substrates, namely glass, single-crystal silicon, quartz and aluminium-coated glass (Synthetic Metals.
55-57 (1993) 2955-2960), and Goldenberg et aL (J. Chem. Soc, Chem. Comm.. 1993. p 1310) have improved on this, but still on rigid bulk substrates only, by using the substituted compound l-tertbutyl-l,9-dihydrofullerene-60. A membrane of for example polyurethane or rubber, e.g. latex rubber, according to the invention carries a coating of from one to ten, preferably 1 or 2, layers of one or more fullerenes. The fullerene(s) may be applied by way of dispersion in a gel or lubrication layer, applied conventionally to the membrane, or as follows.
A method of coating a membrane, according to the invention, comprises applying one or more Langmuir-Blodgett coatings of fullerene to the membrane. The fullerene may be dissolved in an aromatic and/or hydrophobic compound on a hydrophilic (e.g. water) subphase. The fullerene may be codissolved with a phospholipid or fatty acid, e.g. arachidic acid, in a mole proportion of 1 :(1-10) and/or may be substituted with alkyl chains Cj-Cjg or with functionalised chains containing amine, hydroxyl or carboxy lie acid groups, e.g. may be 1 -tertbutyl- 1.9-dihydrofullerene-60.
The invention extends to products such as surgical gloves and condoms made of a membrane which has a coating as set forth above.
The invention will now be described by way of example.
A Langmuir-Blodgett trough of a constant perimeter design of floating boom was housed in a microelectronics-grade clean room. The subphase in the trough was ultra-pure water (pH 5.7 ± 0.1, temperature 20 ± 2°C) obtained by reverse osmosis, deionization and
UV sterilization.
Onto the subphase and inside the adjustable perimeter floating on the surface of the subphase were placed a few drops (150 μl) of a concentrated solution of 1 mole part Cgø fullerene and 4 parts arachidic acid in benzene. One hour was allowed to pass, to ensure complete evaporation of the benzene. The perimeter was adjusted until the fullerene plus arachidic acid formed a close-packed and ordered arrangement, this being established by compressing the perimeter such as to maintain a surface pressure of 30 milliNewtons/m.
This arrangement is believed to be of vertically aligned fatty acid molecules in a close-packed ordered arrangement on the subphase (water) surface, with the fullerene molecules on tog. This arrangement is transferred "as is" to a solid substrate dipped into the Langmuir-Blodgett trough.
When a substrate is dipped into the trough and removed, it may have adhering to it a layer of aligned molecules which became attached: on the downstroke only (X-type deposition), on the downstroke and again on the upstroke (Y-type deposition), or on the upstroke only (Z-type deposition). The thoroughness or efficiency of deposition is measured by the deposition ratio, defined as (change in enclosed surface area of trough)/(dipped area of substrate).
Initially, attempts were made to dip on to commercially available condoms, which were first washed in a mild detergent/warm water solution to remove any lubrication. Dipping was, however, unsuccessful as residual lubrication turned out to have remained on the condom, transferring to the subphase surface as the substrate was lowered into the subphase. This was monitored by an increase in surface area of the floating film, instead of the expected decrease which accompanies loss of material from the subphase surface. Further attempts to clean the condoms resulted in a deterioration of the latex rubber. LB film transfer was unsuccessful.
A pair of hospital-grade starch-free latex rubber surgeon gloves was obtained and a finger was removed from a glove. The finger was stretched over a 1 cm diameter glass test tube. Once again, on transferring the substrate through the subphase a surface area increase was monitored. It was, however, found possible to remove this unknown coating by repeatedly dipping the substrate through a clean subphase/air interface. Following this cleaning procedure, Y-type Langmuir-Blodgett deposition occurred at a dipping speed of - 7.5 mm min"*. The deposition ratio was 1.0 ± 0.05 and the film thickness estimated to be 7.2 nm. This was too thin to affect the appearance of the substrate. Z-type deposition was recorded for a dry condom, supplied by the London Rubber
Company, with a deposition ratio approaching 1.0.

Claims

1. A membrane carrying a coating of from one to ten layers of one or more fullerenes.
2. A membrane according to Claim 1 , wherein the coating is of one or two said layers.
3. A membrane according to Claim 1 or 2, wherein the membrane is of polyurethane or rubber.
4. A membrane according to Claim 3, wherein the membrane is of latex rubber;.
5. A method of coating a membrane, comprising applying one or more Langmuir-Blodgett layers of fullerene to the membrane.
6. A method of making a membrane according to any of Claims 1 to 4, comprising applying one or more Langmuir-Blodgett layers of fullerene to the membrane.
7. A method according to Claim 5 or 6, wherein the fullerene is dissolved in an aromatic and/or hydrophobic compound on a hydrophilic subphase.
8. A method according to Claim 7, wherein the fullerene is codissolved with a phospholipid or fatty acid.
9. A method according to Claim 8, wherein the fullerene and the phospholipid/fatty acid are present in a mole ratio of 1 :(1-10).
10. A method according to Claim 8 or 9, wherein the fatty acid is arachidic acid.
11. A method according to any of Claims 5 to 10, wherein the fullerene is substituted with a Cj_ιg alkyl chain or with a functionalised chain containing an amine, hydroxyl or carboxylic acid group.
12. A method according to Claim 11, wherein the fullerene is l-tertbutyl-1,9- dihy drofullerene-60.
13. A membrane coated by the method of any of Claims 5 to 12.
14. A surgical glove or condom comprising a membrane according to any of Claims 1 to 4 or 13.
PCT/GB1995/000194 1994-02-10 1995-01-31 Membrane with anti-viral properties WO1995021637A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9402581.4 1994-02-10
GB9402581A GB9402581D0 (en) 1994-02-10 1994-02-10 Membrane with anti-viral properties

Publications (1)

Publication Number Publication Date
WO1995021637A1 true WO1995021637A1 (en) 1995-08-17

Family

ID=10750183

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/000194 WO1995021637A1 (en) 1994-02-10 1995-01-31 Membrane with anti-viral properties

Country Status (2)

Country Link
GB (1) GB9402581D0 (en)
WO (1) WO1995021637A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044357A2 (en) * 1999-01-29 2000-08-03 Max-Delbrück-Centrum für Molekulare Medizin Agent for preventing in-stent restenoses and post-operative inflammations
EP1039944A1 (en) * 1997-12-19 2000-10-04 Cordis Corporation Catheter system having fullerenes and method
WO2015068174A2 (en) 2013-11-11 2015-05-14 Hll Lifecare Limited Graphene based polymer composites for producing condoms with high heat transfer, improved sensitivity and capacity for drug delivery
US9376609B2 (en) 2010-12-21 2016-06-28 Halliburton Energy Services, Inc. Settable compositions comprising interground perlite and hydraulic cement

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000552A1 (en) * 1992-06-22 1994-01-06 The Trustees Of Dartmouth College Fullerene coated surfaces and uses thereof
EP0582221A1 (en) * 1992-08-06 1994-02-09 Hoechst Aktiengesellschaft Laminate and method of manufacture

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000552A1 (en) * 1992-06-22 1994-01-06 The Trustees Of Dartmouth College Fullerene coated surfaces and uses thereof
EP0582221A1 (en) * 1992-08-06 1994-02-09 Hoechst Aktiengesellschaft Laminate and method of manufacture

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FRIEDMAN SH ET AL.: "INHIBITION OF THE HIV-1 PROTEASE BY FULLERENE DERIVATIVES: MODEL BUILDING STUDIES AND EXPERIMENTAL VERIFICATION.", J. AM. CHEM. SOC., vol. 115, no. 15, 1993, pages 6506 - 6509 *
G. WILLIAMS ET AL.: "LANGMUIR-BLODGETT FILMS OF THE FULLERENES C70 AND C60.", SYNTHETIC METALS, vol. 56, no. 2&3, 5 April 1993 (1993-04-05), pages 2955 - 2960 *
GOLDENBERG LM ET AL.: "ELECTROCHEMICAL STUDIES ON LANGMUIR-BLODGETT FILMS OF 1-TERT-BUTYL-1,9-DIHYDROFULLERENE-60.", J. CHEM. SOC., CHEM. COMMUN., 1993, pages 1310 - 1312 *
SCHINAZI RF ET AL.: "SYNTHESIS AND VIRUCIDAL ACTIVITY OF A WATER-SOLUBLE CONFIGURATIONALLY STABLE, DERIVATIZED C60 FULLERENE.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 37, no. 8, August 1993 (1993-08-01), pages 1707 - 1710 *
SIJBESMA R. ET AL.: "SYNTHESIS OF A FULLERENE DERIVATIVE FOR THE INHIBITION OF HIV ENZYMES.", J. AM. CHEM. SOC., vol. 115, no. 5, 1993, pages 6510 - 6512 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1039944A1 (en) * 1997-12-19 2000-10-04 Cordis Corporation Catheter system having fullerenes and method
EP1039944A4 (en) * 1997-12-19 2001-04-11 Cordis Corp Catheter system having fullerenes and method
US6468244B1 (en) 1997-12-19 2002-10-22 James E. Leone Catheter system having fullerenes and method
WO2000044357A2 (en) * 1999-01-29 2000-08-03 Max-Delbrück-Centrum für Molekulare Medizin Agent for preventing in-stent restenoses and post-operative inflammations
WO2000044357A3 (en) * 1999-01-29 2001-04-26 Max Delbrueck Centrum Agent for preventing in-stent restenoses and post-operative inflammations
US9376609B2 (en) 2010-12-21 2016-06-28 Halliburton Energy Services, Inc. Settable compositions comprising interground perlite and hydraulic cement
WO2015068174A2 (en) 2013-11-11 2015-05-14 Hll Lifecare Limited Graphene based polymer composites for producing condoms with high heat transfer, improved sensitivity and capacity for drug delivery

Also Published As

Publication number Publication date
GB9402581D0 (en) 1994-04-06

Similar Documents

Publication Publication Date Title
Sorribas et al. Photolithographic generation of protein micropatterns for neuron culture applications
Qu et al. Regenerable smart antibacterial surfaces: full removal of killed bacteria via a sequential degradable layer
Han et al. Combinational biomimicking of lotus leaf, mussel, and sandcastle worm for robust superhydrophobic surfaces with biomedical multifunctionality: antithrombotic, antibiofouling, and tissue closure capabilities
US6444321B1 (en) Reversibly, non-covalent bound surface coating
US20110104452A1 (en) Block copolymer morphology trapping in thin films using low temperature treatment and annealing for inhibition of marine organism attachment to surfaces
US20010046564A1 (en) Assembly of free-standing films using a layer-by-layer process
US7405034B2 (en) Polymeric structures, particularly microstructures, and methods for making same
WO2005042646A2 (en) Surface treatments and modifications using nanostructure materials
US9550809B2 (en) High affinity metal-oxide binding peptides with reversible binding
CA2471103A1 (en) Reagent and method for providing coatings on surfaces
CN101023123A (en) Thin-filmy polymeric structure and method of preparing the same
US20100028719A1 (en) Surface-Immobilized Antimicrobial Peptoids
WO1995021637A1 (en) Membrane with anti-viral properties
CN109200835A (en) A kind of preparation method of bionical building polyquarternium-type antibacterial pvdf membrane
EP1824913A2 (en) Immobilizing anti-microbial compounds on elastomeric articles
Wanka et al. Fouling-release properties of dendritic polyglycerols against marine diatoms
Dolid et al. Combining chemistry and topography to fight biofilm formation: Fabrication of micropatterned surfaces with a peptide-based coating
GB2286348A (en) Membrane with anti-viral properties
CN114450153A (en) Substrate for electronic skin
Vogler Role of water in biomaterials
JP7240401B2 (en) Structuring of surface-active polymers
JPH0490877A (en) Method for modifying surface of material
WO2002081104A2 (en) Beta-sheet tapes of dn1 peptide coatings
CN109595132A (en) The brake of the production method of the actuator of more stimuli responsives and more stimuli responsives
JP2003531390A (en) Uses of prokaryotic second cell wall polymers

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase